Mochida Pharmaceutical Co., Ltd. (FRA:MFY)

Mochida Pharmaceutical Revenue

Mochida Pharmaceutical had revenue of 28.35B JPY in the quarter ending September 30, 2025, with 10.37% growth. This brings the company's revenue in the last twelve months to 109.05B, up 4.35% year-over-year. In the fiscal year ending March 31, 2025, Mochida Pharmaceutical had annual revenue of 105.16B with 2.21% growth.

• Revenue (ttm): 109.05B JPY
• Revenue Growth: +4.35%
• P/S Ratio: 1.07
• Revenue / Employee: 72.31M JPY
• Employees: 1,508
• Market Cap: 673.61M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	105.16B	2.27B	2.21%
Mar 31, 2024	102.89B	-376.00M	-0.36%
Mar 31, 2023	103.26B	-6.92B	-6.28%
Mar 31, 2022	110.18B	7.18B	6.98%
Mar 31, 2021	103.00B	1.20B	1.17%